Literature DB >> 10203344

Interleukin-6 and its soluble receptor in serum and cerebrospinal fluid after cerebral trauma.

V H Hans1, T Kossmann, H Joller, V Otto, M C Morganti-Kossmann.   

Abstract

Interleukin-6 (IL-6) and its soluble receptor (sIL-6-R) were measured in cerebrospinal fluid (CSF) and serum of 11 severely head injured patients for up to 3 weeks following trauma. IL-6 increased immediately after injury displaying much higher concentrations in CSF than in serum (n = 11). Differently, median levels of sIL-6-R remained in the normal ranges being 10 times higher in serum than in CSF. However, increased amounts over control levels were found in CSF (n = 7) and intrathecal release of sIL-6-R was also suggested (n = 7). Although no correlation with the extent of cerebral lesion or with clinical outcome was evident, elevation of sIL-6-R in CSF supports a pivotal role for IL-6/sIL-6-R complex in the injured brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203344     DOI: 10.1097/00001756-199902050-00036

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  18 in total

Review 1.  [The relevance of the inflammatory response in the injured brain].

Authors:  O I Schmidt; I Leinhase; E Hasenboehler; S J Morgan; P F Stahel
Journal:  Orthopade       Date:  2007-03       Impact factor: 1.087

2.  Acute phase response after fatal traumatic brain injury.

Authors:  Benjamin Ondruschka; Sandra Schuch; Dirk Pohlers; Heike Franke; Jan Dreßler
Journal:  Int J Legal Med       Date:  2018-01-06       Impact factor: 2.686

3.  Anti-IL-6 neutralizing antibody modulates blood-brain barrier function in the ovine fetus.

Authors:  Jiyong Zhang; Grazyna B Sadowska; Xiaodi Chen; Seon Yeong Park; Jeong-Eun Kim; Courtney A Bodge; Erin Cummings; Yow-Pin Lim; Oleksandr Makeyev; Walter G Besio; John Gaitanis; William A Banks; Barbara S Stonestreet
Journal:  FASEB J       Date:  2015-01-21       Impact factor: 5.191

4.  Transcriptome analysis of HIV-infected peripheral blood monocytes: gene transcripts and networks associated with neurocognitive functioning.

Authors:  Andrew J Levine; Steve Horvath; Eric N Miller; Elyse J Singer; Paul Shapshak; Gayle C Baldwin; Otoniel Martínez-Maza; Mallory D Witt; Peter Langfelder
Journal:  J Neuroimmunol       Date:  2013-09-26       Impact factor: 3.478

5.  Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury.

Authors:  Georgene W Hergenroeder; Anthony N Moore; J Philip McCoy; Leigh Samsel; Norman H Ward; Guy L Clifton; Pramod K Dash
Journal:  J Neuroinflammation       Date:  2010-03-11       Impact factor: 8.322

6.  Angiotensin II Causes Neuronal Damage in Stretch-Injured Neurons: Protective Effects of Losartan, an Angiotensin T1 Receptor Blocker.

Authors:  P M Abdul-Muneer; Saurav Bhowmick; Nicholas Briski
Journal:  Mol Neurobiol       Date:  2017-11-08       Impact factor: 5.590

7.  Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients.

Authors:  Tomasz Dziedzic; Elzbieta A Gryz; Wojciech Turaj; Agnieszka Slowik; Andrzej Szczudlik
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  The genomic profile of the cerebral cortex after closed head injury in mice: effects of minocycline.

Authors:  Peter J Crack; Jodee Gould; Nicole Bye; Shelley Ross; Uğur Ali; Mark D Habgood; Cristina Morganti-Kossman; Norman R Saunders; Paul J Hertzog
Journal:  J Neural Transm (Vienna)       Date:  2008-11-19       Impact factor: 3.575

9.  Temporal profile of cerebrospinal fluid, plasma, and brain interleukin-6 after normothermic fluid-percussion brain injury: effect of secondary hypoxia.

Authors:  Katina Chatzipanteli; Elizabeth Vitarbo; Ofelia F Alonso; Helen M Bramlett; W Dalton Dietrich
Journal:  Ther Hypothermia Temp Manag       Date:  2012-12       Impact factor: 1.286

10.  Post-injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury.

Authors:  S-F Chen; C-W Hsu; W-H Huang; J-Y Wang
Journal:  Br J Pharmacol       Date:  2008-09-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.